• Exchange: Munich
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

CSJ:GR

50.135 EUR 0.302 0.61%

As of 02:23:00 ET on 09/19/2014.

Snapshot for CSL Ltd (CSJ)

Open: 50.290 Day's Range: 50.135 - 50.730 Volume: 0
Previous Close: 49.833 52wk Range: 42.000 - 53.540 1-Yr Rtn: +13.33%

Stock Chart for CSJ

No chart data available.
  • CSJ:GR 50.135
  • 1D
  • 1M
  • 1Y
49.833
Interactive CSJ Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CSJ

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) 20.6411
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (06/2015) 3.1170
Est. PEG Ratio 1.6313
Market Cap (M EUR) 23,856.00
Shares Outstanding (M) 475.84
30 Day Average Volume 39
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.70%
Cash Dividend (AUD) 0.6485
Dividend Ex-Date 09/08/2014
5 Year Dividend Growth 17.04%
Next Earnings Announcement 02/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CSJ

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CSJ

CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection and pain medicine, skin disorder remedies, antivenoms, anticoagulants and immunoglobulins.

John ShineChairmanPaul PerreaultCEO/Managing Director
Gordon NaylorChief Financial OfficerMary SontropExec VP:Manufacturing
More Company Profile & Key Executives for CSJ

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil